Jobs / United States / Regeneron Pharmaceuticals INC
Principal Pathologist
Regeneron Pharmaceuticals INC · 🇺🇸 TARRYTOWN
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Regeneron Pharmaceuticals INC
The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Regeneron Pharmaceuticals INC →
About the role
Build Our Future Together: The Pathology group within Regeneron’s Drug Safety and Pharmacometrics organization is looking for a Principal Pathologist who is excited to help advance innovative medicines from discovery through development. In this highly collaborative role, you will provide critical pathology expertise across the drug development continuum, including pathology peer review of Regeneron toxicology studies and close partnership with research scientists to support the discovery, characterization, and preclinical development of diverse therapeutic modalities, including large-molecule therapeutics, gene therapies, and oligonucleotide-based drugs targeting a broad range of diseases. When & Where: This position will be based on-site in our Tarrytown, NY offices four days per week. Discover Your Role: • Apply your expertise in toxicologic pathology to help shape research programs that support the discovery and development of transformative medicines. • Serve as the study pathologist for in-house discovery studies and produce high-quality pathology reports that inform scientific decision-making and support regulatory submissions. • Provide digital or glass-slide pathology peer review for Regeneron toxicology studies conducted at contract research organizations. • Leverage digital image analysis, when appropriate, to strengthen study interpretation and scientific insight. • Contribute to the continued development of a forward-looking, in-house digital pathology program. • Present your scientific contributions through internal and external forums that support regulatory and discovery programs. • Contribute to scientific publications, including manuscripts, abstracts, posters, and oral presentations. • Stay connected with the toxicologic pathology community through seminars, workshops, and conferences. This Role Requires: • DVM or PhD in Pathology • 2 years of professional experience relevant to the position • Board certification in veterinary anatomic pathology (DACVP or DECVP). • Experience at a contract research organization is preferred. Does this sound like you? Apply now to take your first step towards living the Regeneron Way! We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship. Where necessary, we disclose salary ranges for roles in all countries in which we operate. The final offer will be determined within the relevant range based on the country of employment, specific role level, and your skills and experience. In some countries, collective bargaining agreements (CBAs) may apply and influence certain elements of pay or benefits. Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role: annual bonuses or other incentive plans, equity awards, pension or retirement benefits, 401(k) company match, health and wellness programs, fitness centers, insurance benefits (e.g. medical, dental, vision, life and disability), paid time off, and family support bene